HSCS - Heart Test Laboratories Sales Growth YoY (TTM)

Heart Test Laboratories generates revenue through the implementation of AI electrocardiography systems and cloud software. Year-over-year revenue changes over the trailing twelve months (TTM) demonstrate the resilience of the fundamental trend, with the latest parameter standing at -28.20. Strong pricing power within MyoVista cardiac diagnostics ensures stable demand, although expansion rates are constrained by the anticipation of final FDA approval for mass scoring.

This indicator tracks the daily change in trailing twelve months (TTM) annual revenue relative to the previous year, allowing investors to promptly identify a slowdown in business expansion or the risk of declining margins. By analyzing the year-over-year (YoY) sales dynamics over the trailing 12 months, one can confirm the efficiency of the planned capacity utilization at Heart Test Laboratories (HSCS) and the readiness of the hardware infrastructure for mass production.